citalopram

1
Reactions 962 - 2 Aug 2003 S Citalopram Hyponatraemia in an elderly patient: case report A 74-year-old woman developed postoperative hyponatraemia while receiving citalopram for depression. The woman had been receiving treatment with citalopram 20 mg/day [duration of therapy not stated] when she underwent total knee replacement surgery with subarachnoid anaesthesia and midazolam sedation. On postoperative day 1 she felt nauseous and dizzy and on day 2 she became less communicative and confused then unresponsive and made uncoordinated clonic limb movements. Her pupils were dilated bilaterally and responded slowly to light, and she had a Glascow Coma Scale score of 5. She was clinically euvolaemic, well oxygenated and cardiovascularly stable. She was ventilated and transferred to the ICU, at which time she had a serum sodium level of 116 mmol/L; presurgery it had been 136 mmol/L. Over the next 2 days the woman’s fluids were restricted, citalopram was discontinued and she received empirical antibacterial treatment. She made a full and uneventful recovery and, on postoperative day 4, was discharged from the ICU with a serum sodium level of 130 mmol/L; this had increased to 134 mmol/L on postoperative day 30. Citalopram was not recommenced. Author comment: "We hypothesize that a combination of risk factors including increased age, female gender, stress response to surgery and citalopram therapy particularly predisposed this patient to hyponatraemia." Holland S, et al. Citalopram - a risk factor for postoperative hyponatraemia. Anaesthesia 58: 491-492, May 2003 - England 800941431 1 Reactions 2 Aug 2003 No. 962 0114-9954/10/0962-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: trantruc

Post on 21-Mar-2017

214 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Citalopram

Reactions 962 - 2 Aug 2003

SCitalopram

Hyponatraemia in an elderly patient: case reportA 74-year-old woman developed postoperative

hyponatraemia while receiving citalopram for depression.The woman had been receiving treatment with citalopram

20 mg/day [duration of therapy not stated] when sheunderwent total knee replacement surgery with subarachnoidanaesthesia and midazolam sedation. On postoperative day 1she felt nauseous and dizzy and on day 2 she became lesscommunicative and confused then unresponsive and madeuncoordinated clonic limb movements. Her pupils weredilated bilaterally and responded slowly to light, and she had aGlascow Coma Scale score of 5. She was clinically euvolaemic,well oxygenated and cardiovascularly stable. She wasventilated and transferred to the ICU, at which time she had aserum sodium level of 116 mmol/L; presurgery it had been 136mmol/L.

Over the next 2 days the woman’s fluids were restricted,citalopram was discontinued and she received empiricalantibacterial treatment. She made a full and uneventfulrecovery and, on postoperative day 4, was discharged from theICU with a serum sodium level of 130 mmol/L; this hadincreased to 134 mmol/L on postoperative day 30. Citalopramwas not recommenced.

Author comment: "We hypothesize that a combination ofrisk factors including increased age, female gender, stressresponse to surgery and citalopram therapy particularlypredisposed this patient to hyponatraemia."Holland S, et al. Citalopram - a risk factor for postoperative hyponatraemia.Anaesthesia 58: 491-492, May 2003 - England 800941431

1

Reactions 2 Aug 2003 No. 9620114-9954/10/0962-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved